Logo image of MYNA

MYNARIC AG NA O.N. (MYNA) Stock Fundamental Analysis

NASDAQ:MYNA - Nasdaq - US62857X1019 - ADR

0.444  +0.02 (+4.47%)

After market: 0.4199 -0.02 (-5.43%)

Fundamental Rating

2

MYNA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 65 industry peers in the Aerospace & Defense industry. MYNA has a bad profitability rating. Also its financial health evaluation is rather negative. MYNA shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MYNA had negative earnings in the past year.
MYNA had a negative operating cash flow in the past year.
In the past 5 years MYNA always reported negative net income.
MYNA had a negative operating cash flow in each of the past 5 years.
MYNA Yearly Net Income VS EBIT VS OCF VS FCFMYNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M

1.2 Ratios

MYNA has a Return On Assets of -78.54%. This is amonst the worse of the industry: MYNA underperforms 87.50% of its industry peers.
Industry RankSector Rank
ROA -78.54%
ROE N/A
ROIC N/A
ROA(3y)-70.83%
ROA(5y)-51.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MYNA Yearly ROA, ROE, ROICMYNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

1.3 Margins

MYNA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MYNA Yearly Profit, Operating, Gross MarginsMYNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K

More info and screens

0

2. Health

2.1 Basic Checks

MYNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
MYNA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MYNA has more shares outstanding
MYNA has a worse debt/assets ratio than last year.
MYNA Yearly Shares OutstandingMYNA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
MYNA Yearly Total Debt VS Total AssetsMYNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

MYNA has an Altman-Z score of -5.27. This is a bad value and indicates that MYNA is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -5.27, MYNA is not doing good in the industry: 90.63% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.27
ROIC/WACCN/A
WACC16.8%
MYNA Yearly LT Debt VS Equity VS FCFMYNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M

2.3 Liquidity

MYNA has a Current Ratio of 0.74. This is a bad value and indicates that MYNA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.74, MYNA is doing worse than 90.63% of the companies in the same industry.
MYNA has a Quick Ratio of 0.74. This is a bad value and indicates that MYNA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.44, MYNA is doing worse than 92.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.44
MYNA Yearly Current Assets VS Current LiabilitesMYNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

MYNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.02%.
MYNA shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.89%.
Measured over the past years, MYNA shows a very strong growth in Revenue. The Revenue has been growing by 31.63% on average per year.
EPS 1Y (TTM)-14.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.86%
Revenue 1Y (TTM)21.89%
Revenue growth 3Y99.48%
Revenue growth 5Y31.63%
Sales Q2Q%-78.12%

3.2 Future

MYNA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.50% yearly.
Based on estimates for the next years, MYNA will show a very strong growth in Revenue. The Revenue will grow by 72.08% on average per year.
EPS Next Y12.07%
EPS Next 2Y18.46%
EPS Next 3Y21.5%
EPS Next 5YN/A
Revenue Next Year-33.12%
Revenue Next 2Y42.55%
Revenue Next 3Y72.08%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MYNA Yearly Revenue VS EstimatesMYNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
MYNA Yearly EPS VS EstimatesMYNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MYNA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MYNA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYNA Price Earnings VS Forward Price EarningsMYNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYNA Per share dataMYNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

MYNA's earnings are expected to grow with 21.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.46%
EPS Next 3Y21.5%

More info and screens

0

5. Dividend

5.1 Amount

MYNA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MYNARIC AG NA O.N.

NASDAQ:MYNA (1/17/2025, 8:16:51 PM)

After market: 0.4199 -0.02 (-5.43%)

0.444

+0.02 (+4.47%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)10-03 2024-10-03
Earnings (Next)N/A N/A
Inst Owners7.76%
Inst Owner Change0%
Ins Owners3.58%
Ins Owner ChangeN/A
Market Cap11.22M
Analysts38
Price Target-0.96 (-316.22%)
Short Float %4.93%
Short Ratio1.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-40.8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.89%
Revenue NY rev (3m)-3.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.93
EYN/A
EPS(NY)-2.94
Fwd EYN/A
FCF(TTM)-1.38
FCFYN/A
OCF(TTM)-1.18
OCFYN/A
SpS0.22
BVpS-2.01
TBVpS-2.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -78.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-70.83%
ROA(5y)-51.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 42.34%
Cap/Sales 91.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.74
Quick Ratio 0.44
Altman-Z -5.27
F-Score3
WACC16.8%
ROIC/WACCN/A
Cap/Depr(3y)142.1%
Cap/Depr(5y)386.08%
Cap/Sales(3y)270.71%
Cap/Sales(5y)968.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.86%
EPS Next Y12.07%
EPS Next 2Y18.46%
EPS Next 3Y21.5%
EPS Next 5YN/A
Revenue 1Y (TTM)21.89%
Revenue growth 3Y99.48%
Revenue growth 5Y31.63%
Sales Q2Q%-78.12%
Revenue Next Year-33.12%
Revenue Next 2Y42.55%
Revenue Next 3Y72.08%
Revenue Next 5YN/A
EBIT growth 1Y-4.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.67%
EBIT Next 3Y28.4%
EBIT Next 5YN/A
FCF growth 1Y44.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.28%
OCF growth 3YN/A
OCF growth 5YN/A